Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT05680311

Autotaxin: a Potential Biomarker for Breast Cancer.

Conditions: Breast Cancer

Sex: Female

Ages: 18 Years – 80 Years

Healthy volunteers: 1

Phase: NA

Enrollment: 110

Sponsor: Ankara Etlik City Hospital

Location: Turkey

Summary

The goal of this clinical trial is to test the efficiency of Autotaxin (ATX) as a biomarker for breast cancer patients.The main questions it aims to answer are;is ATX a reliable tumor marker for breast cancer patients in diagnosiscan ATX differentiate cancer patients from non-cancer ones

Eligibility Criteria

Inclusion Criteria:Preoperatively diagnosed breast cancer patients with no synchronous cancer and without known hepatic or other inflammatory disorders.Exclusion Criteria:Patients with benign breast diseases and no known cancer history.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05680311). StuddyBuddy aggregates publicly available trial information.